GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.10
-0.05 (-0.13%)
Apr 29, 2026, 11:33 AM CST
-18.76%
Market Cap 1.58B
Revenue (ttm) 677.10M
Net Income (ttm) 28.86M
Shares Out 41.46M
EPS (ttm) 0.70
PE Ratio 54.80
Forward PE n/a
Dividend 0.70 (1.83%)
Ex-Dividend Date n/a
Volume 5,001
Average Volume 28,379
Open 38.15
Previous Close 38.15
Day's Range 38.10 - 38.50
52-Week Range 33.65 - 67.10
Beta 0.01
RSI 42.46
Earnings Date May 11, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as we... [Read more]

Sector Healthcare
Founded 1999
Employees 144
Stock Exchange Taipei Exchange
Ticker Symbol 1796
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.